Who invested in Antidote?
Antidote's investors include Octopus and Merck Global Health Innovation Fund/ Smedvig.

United Kingdom · Funded startup
Funding summaryUpdated 26 Oct 2026
$11Mraised across 1 round since 2017, from 1 source
Antidote's investors include Octopus and Merck Global Health Innovation Fund/ Smedvig.
Antidote has raised $11M across 1 round since 2017.
Antidote's most recent round was an Undisclosed round of $11M in Sept 2017.
Its most recent round, $11M in Sept 2017, is also its largest on record.
Antidote's first round on record, in Sept 2017, was backed by Octopus and Merck Global Health Innovation Fund/ Smedvig.
Antidote's latest named round is an Undisclosed round, in Sept 2017.
Antidote is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.